Analyst Recommendations
5.17 0.11(2.17%)10/04/2024
Inozyme Pharma Inc (INZY)
Inozyme Pharma Inc (INZY)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Buy | 9 |
Outperform | 3 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades